Search results: Sage Journals

Restricted accessCase reportFirst published April, 2015

Denosumab in hypercalcemia of malignancy: A case series

Amanda Dietzek, Kelly Connelly, Michael Cotugno [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published March, 2021

Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy

Attiya A. Khan, Payal K. Gurnani, Gary D. Peksa [...]

Annals of Pharmacotherapy

Restricted accessCase reportFirst published October, 2020

When CKD-MBD is not just CKD-MBD,a case of humoral hypercalcemia of malignancy in a dialysis patient

Pulkit Gandhi, Roopali Goyal Gandhi, Ankur D Shah

Journal of Onco-Nephrology

Open accessCase reportFirst published 2026

Aggressive Seropositive Rheumatoid Arthritis With Diffuse Osteolytic Bone Lesions,Hypercalcemia,and Lymphadenopathy Masquerading as Hematologic Malignancy: A Case Report

Lavanya Kannekanti, Tarun Selvarajan, Shilpa Raman Danagara [...]

Journal of Investigative Medicine High Impact Case Reports

Restricted accessCase reportFirst published October, 2019

A case of severe,irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy

Sophie Kim

Journal of Oncology Pharmacy Practice

Open accessCase reportFirst published June, 2023

Hypercalcemia of malignancy with simultaneous production of parathyroid hormone-related peptide and 1,25-Dihydroxyvitamin D by non-Hodgkin lymphoma: Case report & brief review

Eduarda Carias, Hugo Ferreira, Teresa Chuva [...]

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2021

Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients

Michael T Sheehan, Ya-Huei Li, Suhail A Doi [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Restricted accessResearch articleFirst published August, 2021

Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction

Sarah J. Norman, David J. Reeves, Lindsay M. Saum

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published June, 2023

Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction

Christy J Khouderchah, Victoria R Nachar, Rachel L McDevitt [...]

Journal of Onco-Nephrology

Restricted accessResearch articleFirst published February, 1990

Serum Bone Gla-Protein in Hypercalcemia of Primary Hyperparathyroidism and Malignancy

Roberto Di Virgilio, Manuela De Lazzari, Giorgio Da Rin [...]

Tumori Journal

Restricted accessCase reportFirst published April, 2015

Denosumab in hypercalcemia of malignancy: A case series

Amanda Dietzek, Kelly Connelly, Michael Cotugno [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published March, 2021

Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy

Attiya A. Khan, Payal K. Gurnani, Gary D. Peksa [...]

Annals of Pharmacotherapy

Restricted accessCase reportFirst published October, 2020

When CKD-MBD is not just CKD-MBD,a case of humoral hypercalcemia of malignancy in a dialysis patient

Pulkit Gandhi, Roopali Goyal Gandhi, Ankur D Shah

Journal of Onco-Nephrology

Open accessCase reportFirst published 2026

Aggressive Seropositive Rheumatoid Arthritis With Diffuse Osteolytic Bone Lesions,Hypercalcemia,and Lymphadenopathy Masquerading as Hematologic Malignancy: A Case Report

Lavanya Kannekanti, Tarun Selvarajan, Shilpa Raman Danagara [...]

Journal of Investigative Medicine High Impact Case Reports

Restricted accessCase reportFirst published October, 2019

A case of severe,irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy

Sophie Kim

Journal of Oncology Pharmacy Practice

Open accessCase reportFirst published June, 2023

Hypercalcemia of malignancy with simultaneous production of parathyroid hormone-related peptide and 1,25-Dihydroxyvitamin D by non-Hodgkin lymphoma: Case report & brief review

Eduarda Carias, Hugo Ferreira, Teresa Chuva [...]

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2021

Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients

Michael T Sheehan, Ya-Huei Li, Suhail A Doi [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Restricted accessResearch articleFirst published August, 2021

Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction

Sarah J. Norman, David J. Reeves, Lindsay M. Saum

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published June, 2023

Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction

Christy J Khouderchah, Victoria R Nachar, Rachel L McDevitt [...]

Journal of Onco-Nephrology

Restricted accessResearch articleFirst published February, 1990

Serum Bone Gla-Protein in Hypercalcemia of Primary Hyperparathyroidism and Malignancy

Roberto Di Virgilio, Manuela De Lazzari, Giorgio Da Rin [...]

Tumori Journal